Thc Investment Portfolios

Pharmaceuticals
SciSparc Ltd. Announces Promising Phase IIb Trial Results for SCI-110 in Tourette Syndrome Nov 14, 2023
Pharmaceuticals
SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome Nov 13, 2023